Adicet Bio
ACET
49 hedge funds and large institutions have $31.5M invested in Adicet Bio in 2025 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 11 increasing their positions, 15 reducing their positions, and 17 closing their positions.
0.32% less ownership
Funds ownership: 4.22% → 3.9% (-0.32%)
13% less funds holding
Funds holding: 56 → 49 (-7)
25% less capital invested
Capital invested by funds: $42M → $31.5M (-$10.6M)
27% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 15
41% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 17
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SSA
Schonfeld Strategic Advisors
New York
|
+$1.24M |
| 2 |
Renaissance Technologies
New York
|
+$226K |
| 3 |
LM
Luminus Management
Houston,
Texas
|
+$191K |
| 4 |
Barclays
London,
United Kingdom
|
+$98.9K |
| 5 |
WIA
Wealthedge Investment Advisors
New York
|
+$56.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Blackstone Inc
New York
|
-$934K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$520K |
| 3 |
Millennium Management
New York
|
-$416K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$346K |
| 5 |
D.E. Shaw & Co
New York
|
-$319K |
ACET Hedge Fund Activity: Q2 2025 in Review
49 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Adicet Bio (ACET) for Q2 2025, worth a combined $31.5M — down 25% from $42M a quarter earlier.
Sellers outnumbered buyers: 17 funds closed out of ACET and 10 opened new positions — a net loss of 7 holders — while 15 trimmed existing stakes and 11 added.
The largest buyer was Schonfeld Strategic Advisors, opening a new position worth an estimated $1.24M. The largest seller was Blackstone Inc, exiting entirely with an estimated $934K sold.
- 49 institutional investors held Adicet Bio (ACET) as of Q2 2025, down from 56 in Q1 2025.
- Funds reported $31.5M of Adicet Bio stock for Q2 2025, down 25% quarter-over-quarter.
- 10 funds opened new Adicet Bio positions in Q2 2025 and 17 closed out, a net change of -7 holders.
- The largest Adicet Bio buyer in Q2 2025 was Schonfeld Strategic Advisors, an estimated $1.24M added.
- The largest Adicet Bio seller in Q2 2025 was Blackstone Inc, an estimated $934K sold.
Based on aggregated 13F filings for Q2 2025.